Royal Bank Of Canada Altimmune, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Altimmune, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 37,119 shares of ALT stock, worth $271,711. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,119

Previous 31,012 19.69%

Holding current value

$271,711

Previous $206,000 10.19%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.5 - $8.1 $33,588 - $49,466	6,107 Added 19.69%	37,119 $227,000
Q2 2024 Aug 14, 2024	SELL	$5.91 - $10.23 $52,380 - $90,668	-8,863 Reduced 22.23%	31,012 $206,000
Q1 2024 Nov 05, 2024	BUY	$8.22 - $13.81 $72,853 - $122,398	8,863 Added 28.58%	39,875 $405,000
Q1 2024 May 15, 2024	SELL	$8.22 - $13.81 $429,215 - $721,102	-52,216 Reduced 56.7%	39,875 $405,000
Q4 2023 Feb 14, 2024	BUY	$2.14 - $11.62 $179,120 - $972,605	83,701 Added 997.63%	92,091 $1.04 Million
Q3 2023 Nov 14, 2023	SELL	$2.4 - $3.45 $25,555 - $36,735	-10,648 Reduced 55.93%	8,390 $21,000
Q2 2023 Aug 14, 2023	BUY	$3.45 - $5.97 $25,347 - $43,861	7,347 Added 62.84%	19,038 $67,000
Q1 2023 May 15, 2023	BUY	$4.19 - $16.83 $44,263 - $177,792	10,564 Added 937.36%	11,691 $49,000
Q4 2022 Feb 14, 2023	SELL	$8.74 - $16.45 $11,702 - $22,026	-1,339 Reduced 54.3%	1,127 $18,000
Q3 2022 Nov 14, 2022	SELL	$10.67 - $22.41 $62,174 - $130,583	-5,827 Reduced 70.26%	2,466 $31,000
Q2 2022 Aug 15, 2022	BUY	$3.94 - $11.77 $22,454 - $67,077	5,699 Added 219.7%	8,293 $97,000
Q1 2022 May 16, 2022	SELL	$5.9 - $9.45 $35,506 - $56,870	-6,018 Reduced 69.88%	2,594 $16,000
Q4 2021 Feb 14, 2022	BUY	$8.69 - $12.48 $18,622 - $26,744	2,143 Added 33.13%	8,612 $78,000
Q3 2021 Nov 15, 2021	BUY	$8.43 - $16.81 $20,923 - $41,722	2,482 Added 62.25%	6,469 $73,000
Q2 2021 Aug 16, 2021	BUY	$9.85 - $16.46 $39,271 - $65,626	3,987 New	3,987 $39,000

Others Institutions Holding ALT

# of Institutions

186

Shares Held

39.3M

Call Options Held

913K

Put Options Held

743K

View Full List

About Altimmune, Inc.

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $359M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

More about ALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Altimmune, Inc. Transaction History